Aislinn Antrim, Managing Editor

The legislation would require that patients with cancer have access to oral oncology drugs within 72 hours of having the prescription submitted to the patient’s pharmacy benefits manager.

Patients who added dupilumab to standard of care saw a 65% reduction in the rate of severe asthma attacks over 1 year.

Inhibiting Toll-like receptor 4 stopped it from accumulating cisplatin, thereby halting the hearing damage caused by the cancer treatment.

No cases of COVID-19 were observed in the vaccine group using the case definition from the adult phase 3 COVE study, compared to 4 cases in the placebo group.

Breast cancer patients with low or absent MLH1 or PMS2 gene expression may have even greater risks of death.

The basal subtype of ductal adenocarcinoma can be identified by the presence of the DeltaNp63 protein.

Program participants had 55% fewer hospitalizations, 45% fewer emergency department visits, and shorter hospital stays by 1 day in the 30 days after study entry.

Eating a lot of fat and sugar damage Paneth immune cells in the small intestine, which help regulate flora.

High antibody levels were also generated in participants with evidence of a prior SARS-CoV-2 infection, suggesting that this could be developed as a booster.

Myriad issues are responsible, including lack of access and insurance and preexisting disadvantages in underserved populations.

Researchers found no evidence of abnormal blood flow between the mother and fetus or problems with fetal blood flow following COVID-19 vaccination.

Although there is no single playbook that works for all types of practices, some combinations of practice characteristics and operational changes can help practices address cardiovascular disease.

In a trial of amivantamab-vmjw, investigators found an overall response rate of 40% among patients with non-small cell lung cancer whose tumors have epidermal growth factor receptor exon 20 insertion mutations.

Individuals who took probiotics during the 6-month-long study had a 27% lower overall incidence of upper respiratory tract symptoms compared to the placebo group.

Median disease-free survival was twice as long in patients who received nivolumab compared to patients who received a placebo.

In addition to improving health care access for patients, point-of-care testing in pharmacies can drive customer demand and satisfaction.

Vaccines that specifically target the receptor-binding domain of SARS-CoV-2 could be effective, as well as easy to manufacture and scale up.

Despite the stressors of the past year, students said the health care crisis has only reinforced the value of the pharmacist and their desire to enter the field.

The technology demonstrates the important role students can play in pushing the pharmaceutical industry forward.

The primary endpoint of organ failure or death was 11.2% for those receiving dapagliflozin compared to 13.8% for those receiving the placebo.

Supplies of the critical rescue medication for asthma attacks were close to depleted at many hospitals amid COVID-19.

If half of the US population is vaccinated by the summer rather than the fall, 5.8 million cases of COVID-19 could be prevented.

The incidence of colorectal cancer in adults between the ages of 40 and 49 years has increased by nearly 15% since 2000.

Study participants who fasted 2 days per week reported fewer scaling and thickening, with 30% also reporting a decrease in itching associated with psoriasis.

The trial found positive results in both the overall study population of patients with advanced cervical cancer as well as subgroups with squamous cell carcinoma and adenocarcinoma.

As breast cancer becomes an increasingly treatable disease, clinicians should provide personalized follow-up care to address varying burdens of symptoms up to 5 years after diagnosis.

The institution joins 3 other ACPE-accredited pharmacy programs in North Carolina.

High engagement and collaboration between health systems and health plans is essential to implementing value-based models, according to a session at the Pharmacy Quality Alliance 2021 Annual Conference.

Policy changes impacting the star ratings for 2022 include additional flexibility provided during the COVID-19 pandemic and a revised Extreme and Uncontrollable Circumstances policy.

The KEYNOTE-522 trial met its dual primary endpoints of pathologic complete response and event-free survival, showing a statistically significant and clinically meaningful improvement in EFS compared to neoadjuvant chemotherapy alone.